*Clinical Vaccine R&D Center, Chonnam National University ¶Vaxcell-Bio Therapeutics, Hwasun, Jeollanamdo Departments of †Hematology-Oncology ‡Microbiology §Pharmacology and Dental Therapeutics ∥Otolaryngology-Head and Neck Surgery, Chonnam National University, Gwangju, Republic of Korea.
J Immunother. 2014 Jan;37(1):16-25. doi: 10.1097/CJI.0000000000000008.
Flagellin, the cognate ligand for toll-like receptor 5, has potent adjuvant activity in various vaccines. However, its efficacy in generating dendritic cells (DCs) remains contentious. This study assessed how efficaciously Vibrio vulnificus FlaB (v-FlaB) could be used in generating a potent DC to induce antigen-specific cytotoxic T lymphocytes (CTLs). Mature DCs (mDCs) induced by the combination of v-FlaB/TNFα/IFNα were significantly more potent in inducing specific anticancer immune responses compared with the standard DCs that were maturated by the conventional cytokine cocktail of TNFα/IL-1β/IL-6/PGE(2). The potent mDCs produced a higher level of interleukin (IL)-12p70 and polarized naive CD4(+) T cells more towards Th1-type cells, markedly increased antigen-specific CD8(+) T-cell number and significantly enhanced the induction of lytic enzymes in antigen-specific CD8(+) CTLs and sensitized CD3(+) T cells to produce higher number of interferon (IFN)γ-secreting cells. As a result, the mDCs produced more potent antigen-specific CTLs against the MART-1 and expressed higher levels of homing receptors CCR5 and CXCR3. More importantly, the v-FlaB/TNFα/IFNα-DCs generated from melanoma patients produced strong autologous CTLs with efficient cytotoxic activities. In conclusion, v-FlaB combined with tumor necrosis factor (TNF)α and IFNα can generate potent DCs which produce functionally active CTLs and that may have potential as a potent cancer vaccine.
鞭毛蛋白是 Toll 样受体 5 的同源配体,在各种疫苗中具有很强的佐剂活性。然而,其在产生树突状细胞(DC)方面的功效仍存在争议。本研究评估了创伤弧菌 FlaB(v-FlaB)在产生有效的 DC 以诱导抗原特异性细胞毒性 T 淋巴细胞(CTL)方面的功效。与通过 TNFα/IL-1β/IL-6/PGE2 等常规细胞因子鸡尾酒成熟的标准 DC 相比,v-FlaB/TNFα/IFNα 组合诱导的成熟 DC(mDC)在诱导针对特定癌症的免疫反应方面更为有效。产生的强力 mDC 会产生更高水平的白细胞介素(IL)-12p70,并使幼稚 CD4+T 细胞向 Th1 型细胞极化,显著增加抗原特异性 CD8+T 细胞数量,并显著增强抗原特异性 CD8+CTL 中裂解酶的诱导作用以及致敏 CD3+T 细胞产生更多的干扰素(IFN)γ分泌细胞。结果,mDC 产生了针对 MART-1 的更强效的抗原特异性 CTL,并表达了更高水平的归巢受体 CCR5 和 CXCR3。更重要的是,源自黑色素瘤患者的 v-FlaB/TNFα/IFNα-DC 产生了具有高效细胞毒性的强烈自体 CTL。总之,v-FlaB 与肿瘤坏死因子(TNF)α和 IFNα 联合使用可以产生有效的 DC,这些 DC 可以产生功能活跃的 CTL,并且可能具有作为有效癌症疫苗的潜力。